Variant report
Variant | nsv463996 |
---|---|
Chromosome Location | chr6:102571444-102603013 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:12)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:12 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:102569145..102571853-chr6:102574170..102575887,3 | K562 | blood: | |
2 | chr6:102594665..102597425-chr6:102597707..102599339,2 | MCF-7 | breast: | |
3 | chr6:102571736..102574356-chr6:102583811..102586926,3 | K562 | blood: | |
4 | chr6:102594665..102597425-chr6:102597707..102599339,2 | MCF-7 | breast: | |
5 | chr6:102569145..102571791-chr6:102574229..102575887,2 | K562 | blood: | |
6 | chr6:102569145..102571853-chr6:102574170..102575887,3 | K562 | blood: | |
7 | chr6:102572254..102574562-chr6:102580095..102582205,2 | MCF-7 | breast: | |
8 | chr6:102572254..102574562-chr6:102580095..102582205,2 | MCF-7 | breast: | |
9 | chr6:102582072..102584846-chr6:102585321..102586983,2 | MCF-7 | breast: | |
10 | chr6:102582072..102584846-chr6:102585321..102586983,2 | MCF-7 | breast: | |
11 | chr6:102569145..102571791-chr6:102574229..102575887,2 | K562 | blood: | |
12 | chr6:102571736..102574356-chr6:102583811..102586926,3 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ASCC3-1 | chr6:102575603-102575865 | XLOC_005791 |
2 | lnc-ASCC3-1 | chr6:102580356-102580400 | XLOC_005791 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185911853 | chr6:102573885-102573886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs146888978 | chr6:102573910-102573911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs189171254 | chr6:102573919-102573920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139754400 | chr6:102574001-102574002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs77509398 | chr6:102574027-102574028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs377438673 | chr6:102574072-102574073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs372550067 | chr6:102574103-102574104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182575258 | chr6:102574123-102574124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570026898 | chr6:102574132-102574133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375604045 | chr6:102574197-102574198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs146534104 | chr6:102574232-102574233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs17062861 | chr6:102574249-102574250 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs567964999 | chr6:102574309-102574310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs535388070 | chr6:102574335-102574336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187139209 | chr6:102574372-102574373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192002632 | chr6:102574392-102574393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs62421276 | chr6:102574491-102574492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556436209 | chr6:102574495-102574496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs80251170 | chr6:102574629-102574630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182786620 | chr6:102574640-102574641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185538314 | chr6:102574643-102574644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs201310271 | chr6:102574668-102574669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs189947911 | chr6:102574791-102574792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs141304553 | chr6:102574825-102574826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs575205814 | chr6:102574917-102574918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs372060798 | chr6:102574921-102574922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542216684 | chr6:102574956-102574957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10616448 | chr6:102574964-102574965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375385589 | chr6:102574969-102574970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560595352 | chr6:102574997-102574998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs6937643 | chr6:102575003-102575004 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs150211102 | chr6:102575036-102575037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145748576 | chr6:102575037-102575038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs148885236 | chr6:102575039-102575040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs116383521 | chr6:102575060-102575061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs182214716 | chr6:102575082-102575083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530981129 | chr6:102575126-102575127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs549496722 | chr6:102575230-102575231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs9485602 | chr6:102575237-102575238 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs9485603 | chr6:102575257-102575258 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs547294199 | chr6:102575275-102575276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs571813923 | chr6:102575297-102575298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs143545171 | chr6:102575306-102575307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs532839037 | chr6:102575311-102575312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs546134191 | chr6:102575314-102575315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs368102520 | chr6:102575323-102575324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs188050090 | chr6:102575325-102575326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs73502531 | chr6:102575335-102575336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs192276864 | chr6:102575351-102575352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554230957 | chr6:102575372-102575373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21785460 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Obesity | 21045960 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Autism | 22543975 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:102573800-102574200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr6:102573800-102575000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr6:102574000-102574400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr6:102574000-102575400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr6:102574000-102575600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr6:102574000-102575600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr6:102574400-102574800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr6:102574400-102575000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
9 | chr6:102583600-102584000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr6:102596200-102596600 | Enhancers | Brain Germinal Matrix | brain |
11 | chr6:102596600-102597800 | Weak transcription | Brain Germinal Matrix | brain |
12 | chr6:102597800-102598000 | Enhancers | Brain Germinal Matrix | brain |
13 | chr6:102601600-102602000 | Enhancers | Skeletal Muscle Female | skeletal muscle |
14 | chr6:102602000-102602600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr6:102602000-102602600 | Flanking Active TSS | Skeletal Muscle Female | skeletal muscle |
16 | chr6:102602000-102602800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
17 | chr6:102602600-102603000 | Active TSS | Skeletal Muscle Female | skeletal muscle |